Etiometry Platform Featured in Multiple Research Presentations Accepted at the 16th Annual Meeting of the Pediatric Cardiac Intensive Care Society
News and Press Releases
BOSTON, December 1st, 2020 – Etiometry, the leader in clinical decision-support software for critical care, has had multiple research projects accepted for presentation at the 16th Annual International Meeting of the Pediatric Cardiac Intensive Care Society (PCICS), which is being held virtually, Dec. 9-11. Etiometry’s clinical decision-support platform includes FDA-cleared risk algorithms, automatically collected comprehensive physiologic data and vital signs, and permanently stored data in an easily accessible format to support meaningful clinical research.
More than 150 abstracts were submitted to the 2020 conference. Among the top five abstracts being presented December 9th are Dr. Qalab Abbas’, from Aga Khan University Hospital, findings on “Performance of a Predictive Analytic Tool (Index of Tissue Oxygen Delivery ‘IDO2’) in Pediatric Cardiac Intensive Care Unit of a Developing Country.”
Additional work supported by the Etiometry Platform being presented at this year’s conference includes research on data omissions in Electronic Medical Records (EMR) of critically ill patients as well as driving efficiencies in clinical rounding and communications using Etiometry’s automated data collection and aggregation system.
“Improving patient outcomes while decreasing clinician workloads is our top priority. We continue to achieve this goal by better utilizing the billions of data points surging through the ICU at any time. Etiometry is empowering clinicians by transforming critical care data into clinical insights,” explained Etiometry CEO, Shane Cooke.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
PAS 2026 Abstract Reports Association Between IVCO2 Index Implementation and Blood Gas Measurement Frequency in NICU Patients
Boston, Mass., April 27, 2026 – Etiometry announced that a retrospective analysis was presented at the Pediatric Academic Societies (PAS) 2026 Meeting, evaluating changes in blood gas measurement frequency following clinical adoption of its IVCO2 Index in a Level IV Neonatal Intensive Care Unit (NICU). Investigators compared outcomes before and after implementation and reported 10% […]
First FDA-Cleared System Provides Real-Time Data for Cardiogenic Shock
Etiometry was recently featured in a Medscape interview with insights from our co-founder and CTO, Dimitar Baronov, alongside clinicians Walter Schiffer, MD, Cardiologist at Washington University School of Medicine and Srihari Naidu, MD, President of SCAI. The article highlights the importance of early identification in cardiogenic shock and how integrating continuous physiologic data with EHR, […]
Etiometry has been named one of the “Top Most Influential Companies to Watch 2026” by BizTech Outlook.
With recent FDA clearance for the first and only Hospital-Specific Cardiogenic Shock Classification and Tracking tool, we’re expanding how care teams can identify risk earlier and intervene with greater precision. The article highlights how critical care is evolving, using continuous data to help clinicians spot changes sooner and make more informed decisions at the bedside. […]